Virtual Medicinal Product (VMP) - Ledipasvir 45mg / Sofosbuvir 200mg tablets
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Ledipasvir 45mg / Sofosbuvir 200mg tablets | Start Date 15-06-2021 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- Other
Codes
- ATC Code
- J05AP51
- BNF Codes
-
- BNF code 05030302
| Code | Start Date | End Date |
|---|---|---|
| 39819211000001107 | 15-06-2021 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Ledipasvir | Based on Ingredient Substance | 45 mg | ||
| Sofosbuvir | Based on Ingredient Substance | 200 mg |
Name
Sofosbuvir
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
200
Strength and UOM (Dmr)
Name
Ledipasvir
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
45
Strength and UOM (Dmr)
Parent Products
-
VTMLedipasvir + Sofosbuvir
-
VMP(Current) Ledipasvir 45mg / Sofosbuvir 200mg t...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 28 tablet |